We are live on ! Find out more
FMI

F/M Investments Portfolio holdings

AUM $1.97B
1-Year Est. Return 30.33%
This Fund
S&P 500
This Quarter Est. Return
-2.84%
1 Year Est. Return
+30.33%
3 Year Est. Return
+101.46%
5 Year Est. Return
+144.03%
10 Year Est. Return
–
AUM
$2.51B
AUM Growth
-$201M
Cap. Flow
-$78.6M
Cap. Flow %
-3.13%
Top 10 Hldgs %
32.12%
Holding
422
New
23
Increased
129
Reduced
193
Closed
31

Top Buys

Rank Stock Value
1
IDXX icon
Idexx Laboratories
IDXX
+$11.8M
2
C icon
Citigroup
C
+$6.42M
3
BLK icon
Blackrock
BLK
+$5.5M
4
HUBS icon
HubSpot
HUBS
+$4.88M
5
LRCX icon
Lam Research
LRCX
+$4.71M

Top Sells

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$18.7M
2
ZTWO icon
F/M 2-Year Investment Grade Corporate Bond ETF
ZTWO
+$18.5M
3
AAPL icon
Apple
AAPL
+$10.2M
4
TFC icon
Truist Financial
TFC
+$9.55M
5
TBIL
F/m US Treasury 3 Month Bill Fund
TBIL
+$6.55M

Sector Composition

Rank Sector Weight
1 Technology 21.71%
2 Healthcare 11.09%
3 Financials 10.98%
4 Consumer Discretionary 8.01%
5 Industrials 7.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KRG icon
151
Kite Realty
KRG
$5.35B
$3.76M 0.15%
168,129
+474
+0.3% +$10.8K
SBCF icon
152
Seacoast Banking Corp of Florida
SBCF
$3.35B
$3.74M 0.15%
145,531
+1,320
+0.9% +$36K
PJT icon
153
PJT Partners
PJT
$4.36B
$3.69M 0.15%
26,771
+4,545
+20% +$715K
SLNO
154
DELISTED
Soleno Therapeutics
SLNO
$3.63M 0.14%
50,767
+2,973
+6% +$145K
AMD icon
155
Advanced Micro Devices
AMD
$789B
$3.58M 0.14%
34,887
-30,244
-46% -$3.36M
ICUI icon
156
ICU Medical
ICUI
$4.62B
$3.58M 0.14%
25,809
-815
-3% -$126K
BBIO icon
157
BridgeBio Pharma
BBIO
$16.6B
$3.57M 0.14%
103,318
+6,120
+6% +$206K
MPC icon
158
Marathon Petroleum
MPC
$83.5B
$3.54M 0.14%
24,319
-2,959
-11% -$438K
FCX icon
159
Freeport-McMoran
FCX
$97.4B
$3.5M 0.14%
92,456
-3,929
-4% -$150K
TMDX icon
160
Transmedics
TMDX
$2.9B
$3.49M 0.14%
51,867
+979
+2% +$67.3K
AVNT icon
161
Avient
AVNT
$4.21B
$3.44M 0.14%
92,615
+1,077
+1% +$44.5K
GOOG icon
162
Alphabet (Google) Class C
GOOG
$4.33T
$3.42M 0.14%
21,889
-295
-1% -$54K
NUE icon
163
Nucor
NUE
$62.1B
$3.4M 0.14%
28,249
-324
-1% -$41.7K
HAE icon
164
Haemonetics
HAE
$3.97B
$3.29M 0.13%
51,754
-585
-1% -$39.8K
PATK icon
165
Patrick Industries
PATK
$2.94B
$3.26M 0.13%
38,580
-132
-0.3% -$11.9K
IPAR icon
166
Interparfums
IPAR
$3.93B
$3.2M 0.13%
28,142
-419
-1% -$55.6K
LMB icon
167
Limbach Holdings
LMB
$578M
$3.19M 0.13%
42,901
+10,721
+33% +$937K
PTEN icon
168
Patterson-UTI
PTEN
$3.76B
$3.19M 0.13%
388,169
+10,131
+3% +$85K
TOL icon
169
Toll Brothers
TOL
$14.5B
$3.17M 0.13%
29,984
+10,416
+53% +$1.25M
BFC icon
170
Bank First Corp
BFC
$1.7B
$3.12M 0.12%
31,000
– –
IBP icon
171
Installed Building Products
IBP
$6.59B
$3.12M 0.12%
18,209
-366
-2% -$66K
IFF icon
172
International Flavors & Fragrances
IFF
$21.9B
$3.08M 0.12%
39,749
-36,016
-48% -$2.97M
WFC icon
173
Wells Fargo
WFC
$263B
$3.07M 0.12%
42,695
-1,832
-4% -$138K
VIOO icon
174
Vanguard S&P Small-Cap 600 ETF
VIOO
$4.25B
$3.04M 0.12%
31,503
– –
FSLR icon
175
First Solar
FSLR
$26.9B
$2.97M 0.12%
23,499
+14,370
+157% +$2.24M
5 6
7
8 9

Similar funds

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return
NIM
Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return
RMCM
Reynders McVeigh Capital Management Boston, Massachusetts $1.98B AUM 23.37% 1-Year Est. Return
FC
Finepoint Capital Boston, Massachusetts $1.95B AUM 45.61% 1-Year Est. Return
SC
Syon Capital San Francisco, California $1.99B AUM 22.67% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
BC
Blackhill Capital Morristown, New Jersey $1.94B AUM 18.09% 1-Year Est. Return

F/M Investments's Q1 2025 Portfolio in Review

As of Q1 2025, F/M Investments held 422 positions worth $2.51B, down 7.4% from $2.71B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

F/M Investments withdrew a net $78.6M in Q1 2025, closing 31 positions and reducing 193 holdings. Its most notable exit was Intra-Cellular Therapies Inc., an estimated $3.08M position sold in full.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 24% a quarter earlier, followed by Healthcare and Financials.

Against the trend, F/M Investments opened a new position in Idexx Laboratories worth $11.4M.

  • F/M Investments's largest Q1 2025 buy was Idexx Laboratories: 27,178 shares worth $11.4M.
  • F/M Investments added most to Palantir in Q1 2025, an estimated $3.23M increase.
  • F/M Investments's biggest Q1 2025 reduction was UnitedHealth, cutting an estimated $18.7M.
  • F/M Investments fully exited Intra-Cellular Therapies Inc. in Q1 2025, selling an estimated $3.08M.
  • F/M Investments's ten largest holdings make up 32% of its $2.51B portfolio in Q1 2025.
  • F/M Investments opened 23 new positions and closed 31 in Q1 2025.
  • F/M Investments's portfolio value fell 7.4% quarter-over-quarter to $2.51B.

Based on F/M Investments's 13F filing for Q1 2025, filed 14 May 2025.